This meeting took place in 2019
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
HIV Vaccines (X7)
Organizer(s) Nicole A. Doria-Rose, Thumbi Ndung'u and Gunilla Karlsson Hedestam
March 24—28, 2019
Fairmont Chateau Whistler • Whistler, British Columbia Canada
Discounted Abstract Deadline: Dec 5, 2018
Abstract Deadline: Dec 18, 2018
Scholarship Deadline: Dec 5, 2018
Discounted Registration Deadline: Jan 24, 2019
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
Joint Meeting:
Functional Cures and the Eradication of HIV (X8)
Summary of Meeting:
Despite dramatic progress in prevention and treatment of HIV, the pandemic continues, and two million people are newly infected each year. Thus, the need for a preventive vaccine for HIV is as urgent as ever. Intensive research in basic immunology and virology as well as empirical clinical trial data continues to yield insights that inform vaccine efforts. The 2019 HIV Vaccines conference presents the latest results from human clinical studies of candidate vaccines as well as the use of monoclonal antibodies for prevention; novel HIV neutralizing antibodies and their developmental pathways; T cell functions in killing and B cell help; structural insights and immunogen design; and the intersection of research for HIV eradication/cure with research on HIV vaccines, including interventions after very early antiretroviral therapy. The program also includes a session on the process of bringing candidate vaccines to clinical trial, told from the diverse perspectives of laboratory investigators, industrial production, funders and clinical researchers on the front lines.
View Meeting Program
Despite dramatic progress in prevention and treatment of HIV, the pandemic continues, and two million people are newly infected each year. Thus, the need for a preventive vaccine for HIV is as urgent as ever. Intensive research in basic immunology and virology as well as empirical clinical trial data continues to yield insights that inform vaccine efforts. The 2019 HIV Vaccines conference presents the latest results from human clinical studies of candidate vaccines as well as the use of monoclonal antibodies for prevention; novel HIV neutralizing antibodies and their developmental pathways; T cell functions in killing and B cell help; structural insights and immunogen design; and the intersection of research for HIV eradication/cure with research on HIV vaccines, including interventions after very early antiretroviral therapy. The program also includes a session on the process of bringing candidate vaccines to clinical trial, told from the diverse perspectives of laboratory investigators, industrial production, funders and clinical researchers on the front lines.
View Meeting Program
Scholarships/Awards
Burroughs Wellcome Fund ECITA Scholarship Recipients
Pablo Penaloza-MacMasterNorthwestern University, USA
Keystone Symposia Future of Science Fund Scholarship Recipients
Johana TorralbaUniversity of the Basque Country, Spain
National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients
Andrew J. BorstUniversity of Washington, USA
Jean-Francois Bruxelle
Simon Fraser University, Canada
Christopher Andrew Cottrell
The Scripps Research Institute, USA
Adam Dingens
Fred Hutchinson Cancer Research Center, USA
Jeremiah Dallas Heredia
University of Illinois Urbana-Champaign, USA
Samuel W. Kazer
Massachusetts Institute of Technology, USA
Liridona Maliqi
University of Zürich, Switzerland
Sebastian Ols
Karolinska Institute, Sweden
Ian Setliff
Vanderbilt Vaccine Center, USA
Samantha Marie Townsley
Walter Reed Army Institute of Research, USA
Marlies Melanie Van Haaren
Amsterdam UMC, Netherlands
Pathogens and Immunity Scholarship Recipients
Sanjeev KumarAll India Institute of Medical Sciences, India
Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Adeleye Solomon BakareyUniversity of Ibadan, Nigeria
John Martin Buwembo
Uganda Virus Research Institute, Uganda
Himanshi Chawla
All India Institute of Medical Sciences, India
Rebecca Chukwuanukwu
Nnamdi Azikiwe University, Nigeria
Chika Peter Ejikeugwu
Ebonyi State University, Nigeria
Kolawole Asimiyu Fasakin
Federal Teaching Hospital, Nigeria
Ijeoma Mary-Joy Ifeorah
University of Nigeria, |Nsukka, Nigeria
Hope Chioma Innocent-Adiele
New York University School of Medicine, USA
Shivaji K. Jadhav
Lilac Insights, India
Anita Kabarambi
Uganda Virus Research Institute, Uganda
Laban Kato
Medical Research Council, Uganda Virus Research Institute, Uganda
Sakaorat Lertjuthaporn
Mahidol University, Thailand
Mitala Charles Lwanga
Uganda Virus Research Institute, Uganda
Khyati Mayank Modi
Caribbean Medical University, Curaçao
Hasifah Nanyingi
Islamic University, Uganda
Aida Sivro
Centre for the AIDS Programme of Research in South Africa, South Africa
Vinicius Guimarães Suzart
Federal University of Rio de Janeiro - UFRJ, Brazil
Teklu Kiros Woldegebriel
National Yang-Ming University, Taiwan
Kamushaaga Member Zephyrian
MRC/UVRI and London School of Hygiene and Tropical Medicine, Uganda
Panpan Zhou
Tsinghua University, China
